Reindl-Schwaighofer, Roman
Hödlmoser, Sebastian
Domenig, Oliver
Krenn, Katharina
Eskandary, Farsad
Krenn, Simon
Schörgenhofer, Christian
Rumpf, Benedikt
Karolyi, Mario
Traugott, Marianna T.
Abrahamowicz, Agnes
Tinhof, Viktoria
Mayfurth, Hannah
Rathkolb, Vincent
Mußnig, Sebastian
Schmölz, Lukas
Ullrich, Roman
Heinzel, Andreas
König, Franz
Binder, Christina
Bonderman, Diana
Strassl, Robert
Puchhammer-Stöckl, Elisabeth
Gorkiewicz, Gregor
Aberle, Judith H.
Jilma, Bernd
Wenisch, Christoph
Poglitsch, Marko
Oberbauer, Rainer
Zoufaly, Alexander
Hecking, Manfred
Funding for this research was provided by:
Austrian Science Fund (KLI 861-B)
Medical-scientific fund of the Mayor of the federal capital Vienna (MA 40-GMWF-COVID027)
Article History
Received: 9 June 2022
Accepted: 17 November 2022
First Online: 22 November 2022
Competing interests
: Marko Poglitsch and Oliver Domenig are employed by Attoquant Diagnostics, Vienna/Austria, a company that received payments for RAS-Fingerprint and ACE2 measurements. None of the other co-authors declared a competing interest related to the present manuscript.